Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,701,000
Closed -$4.22M 3981
2024
Q1
$4.22M Buy
+1,701,000
New +$4.43M 0.01% 1579
2023
Q4
Sell
-5,055,100
Closed -$13M 3941
2023
Q3
$13M Buy
+5,055,100
New +$14.6M 0.03% 663

Other funds holding ABEV

Squarepoint's ABEV Position: Q2 2026 in Review

Squarepoint reduced its Ambev (ABEV) stake by 64% in Q2 2026, selling an estimated $1.05M and leaving 191,056 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #3282.

Squarepoint first reported a position in ABEV in Q4 2016 and has held it in 26 quarters since. The position peaked at $8.66M in Q3 2023. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Squarepoint held 191,056 shares of Ambev worth $600K as of Q2 2026.
  • Squarepoint sold 334,729 Ambev shares in Q2 2026, an estimated $1.05M.
  • Ambev made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3282 holding.
  • Squarepoint first reported a position in Ambev in Q4 2016 and has held it in 26 quarters since.
  • Squarepoint's Ambev position peaked at $8.66M in Q3 2023.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.